CoChat

Biodistribution, pharmacokinetics and metabolism of interleukin‐1 receptor antagonist (IL‐1RA) using [18F]‐IL1RA and PET imaging in rats

Open access
Cawthorne, C, Prenant, C, Smigova, A, Julyan, P, Maroy, R, Herholz, K, Rothwell, N, Boutin, H · 2011 · British Journal of Pharmacology
Cited by 54

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

BACKGROUND AND PURPOSE: Positron emission tomography (PET) has the potential to improve our understanding of the preclinical pharmacokinetics and metabolism of therapeutic agents, and is easily translated to clinical studies in humans. However, studies involving proteins radiolabelled with clinically relevant PET isotopes are currently limited. Here we illustrate the potential of PET imaging in a preclinical study of the biodistribution and metabolism of 18 F‐labelled IL‐1 receptor antagonist ([18 F]IL‐1RA) using a novel [18 F]‐radiolabelling technique. EXPERIMENTAL APPROACH: IL‐1RA was radiolabelled by reductive amination on lysine moieties with [18 F]fluoroacetaldehyde. Sprague‐Dawley rats were injected intravenously with [18 F]IL‐1RA and imaged with a PET camera for 2 h. For the study of IL‐1RA metabolites by ex vivo γ‐counting of samples, rats were killed 20 min, 1 h or 2 h after injection of [18 F]IL‐1RA. KEY RESULTS: [18 F]IL‐1RA distribution into the major organs of interest was as follows: kidneys >> liver > lungs >> brain. In lungs and liver, [18 F]IL‐1RA uptake peaked within 1 min post‐injection then decreased rapidly to reach a plateau from 10 min post‐injection. In the brain, the uptake exhibited slower pharmacokinetics with a smaller post‐injection peak and a plateau from 6 min onward. IL‐1RA was rapidly metabolized and these metabolites represented ∼40% of total activity in plasma and ∼80% in urine, 20 min after injection. CONCLUSIONS AND IMPLICATIONS Preclinical PET imaging is a feasible method of assessing the biodistribution of new biological compounds of therapeutic interest rapidly. The biodistribution of [18 F]IL‐1RA reported here is in agreement with an earlier study suggesting low uptake in the normal brain, with rapid metabolism and excretion via the kidneys.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.2010.01068.x

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 54

Metadata

Authors
Cawthorne, C., Prenant, C., Smigova, A., Julyan, P., Maroy, R., Herholz, K., Rothwell, N., & Boutin, H.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2011-01-12
Volume
162
Issue
3
Pages
659-672
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1569828475
Cited by
54
References
8
FWCI
3.13
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Biodistribution, pharmacokinetics and metabolism of interleukin‐1 receptor antagonist (IL‐1RA) using [18F]‐IL1RA and PET imaging in rats. https://app.cochat.ai/papers/10.1111/j.1476-5381.2010.01068.x
The paper
Cawthorne, C., Prenant, C., Smigova, A., Julyan, P., Maroy, R., Herholz, K., Rothwell, N., & Boutin, H. (2011). Biodistribution, pharmacokinetics and metabolism of interleukin‐1 receptor antagonist (IL‐1RA) using [18F]‐IL1RA and PET imaging in rats. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2010.01068.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.